Navigation Links
Adam Chasse Inducted Into Delta Omega Public Health Honorary Society
Date:4/24/2012

ELLICOTT CITY, Md., April 24, 2012 /PRNewswire/ -- Adam Chasse, RxTrials' vice president of Corporate Development, was inducted into Delta Omega, the public health honorary society, during ceremonies at the University of North Carolina at Chapel Hill (UNC-CH), on Friday, April 20.

Chasse earned a Master of Healthcare Administration degree in 2011 from the Gillings School of Global Public Health at UNC-CH. He has a long and distinguished career in clinical research, having served in various roles at international CRO Quintiles from 1995 until joining RxTrials last year. At RxTrials, he directs the organization's growth by increasing study volume and enhancing strategic relationships. Throughout his career, Chasse has been committed to improving quality and operational efficiency in clinical research in order to help new medicines get into the hands of the patients that need them.

The Delta Omega Honorary Society in Public Health was founded in 1924 to recognize outstanding achievement in the field of public health. As the scope of public health has broadened, Delta Omega expanded its reach while still recognizing its founding ideals. Today's members come from a broad spectrum of professions dedicated to public health.

"Inasmuch as membership in Delta Omega recognizes dedication to quality and advancement of good health for all, this is a proud personal achievement for me," Chasse said, "but just as importantly, those are the values my RxTrials colleagues and I strive to demonstrate for our patients and our clients every day.  This honor reinforces that commitment."

RxTrials, Inc., is a network of premier clinical research sites that, through partnerships with more than 100 top study sponsors and CROs, has conducted more than 1,000 studies helping to bring new drugs, vaccines and medical devices to market. It also is the parent company of RxTrials Institute, a leading national clinical research consultant and education provider. RxTrials Institute each year presents the Site Solutions Summit, a top networking and business management conference for clinical research sites, sponsors and CROs.


'/>"/>
SOURCE RxTrials, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. RxTrials Announces Hiring Adam Chasse as VP of Business Development
2. Martek Biosciences Inducted into Small Business Innovation Research (SBIR) Hall of Fame
3. Wyle Engineer Inducted Into Space Technology Hall of Fame for Work on Growing Human Cells in Space
4. MiMedx Groups Chairman, Parker H. "Pete" Petit, Is Inducted Into the National Academy of Engineering
5. Applied Precision Installs New DeltaVision
6. OMX® Super-Resolution Imaging System in the Light Microscopy Imaging Center at Indiana University
7. Verenium Launches DELTAZYM® GA L-E5 Enzyme for Fuel Ethanol Production
8. Ed Weimer Joins Delta Point, Inc. as Executive Account Director
9. Applied Precision Announces the 25th Installation of Its DeltaVision OMX Super-Resolution Microscope at McGill University
10. Downsizing and the Need for Increased Selling Effectiveness Fuel Delta Points Growth
11. OmegaGenesis Announces Angiogenesis Application Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... ... 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers use ... 6000i models are higher end machines that use the more unconventional z-dimension of 20mm. ... from the bottom of the cuvette holder. , FireflySci has developed several Agilent ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... ... 23, 2016 , ... Charm Sciences, Inc. is pleased to ... AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of the ... Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably ...
Breaking Biology Technology:
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour ... from the Q1 wave of its quarterly wearables survey. ... receptivity to a program where they would receive discounts ... company. "We were surprised to see that ... LaColla , CEO of Troubadour Research, "primarily because there ...
(Date:4/26/2016)... LONDON , April 26, 2016 /PRNewswire/ ... Systems, a product subsidiary of Infosys (NYSE: ... partnership to integrate the Onegini mobile security platform ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration ... security to access and transact across channels. Using ...
(Date:4/14/2016)... April 14, 2016 BioCatch ... Detection, today announced the appointment of Eyal Goldwerger ... role. Goldwerger,s leadership appointment comes at a ... of the deployment of its platform at several of ... technology, which discerns unique cognitive and physiological factors, is ...
Breaking Biology News(10 mins):